STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
“He will provide expertise and focus across the organization and establish solid partnerships that will enhance our R&D program further. His broad experience grounded in research, medicine and the biopharmaceutical industry is exactly what we need to lead this organization forward.”
NeuroVive Pharmaceutical (STO:NVP)
NeuroVive Pharmaceutical AB (publ) board of directors is pleased to announce that it has selected Erik Kinnman as NeuroVive’s Chief Executive Officer (CEO). Erik Kinnman will assume the new role on the 14th March 2016, leaving Chief Medical Officer (CMO) and Chief Operating Officer (COO) roles within his own consultancy business.
